{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T01:59:43Z","timestamp":1769997583056,"version":"3.49.0"},"reference-count":41,"publisher":"Scientific Scholar","content-domain":{"domain":["cytojournal.com"],"crossmark-restriction":true},"short-container-title":["Cytojournal"],"abstract":"<jats:sec id=\"st1\">\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Treating triple-negative breast cancer (TNBC) is a major challenge owing to its unique biological characteristics. This study aimed to elucidate the molecular interaction between microRNA-15a-5p and T-cell immunoreceptor associated with immunoglobulin and ITIM domains (TIGIT) in TNBC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st2\">\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>The GSE22513 microarray dataset was subjected to bioinformatic analysis. MDA-MB-231 and MDA-MB-468 cells were transfected with lentiviral constructs for overexpressing TIGIT and microRNA (miRNA) mimics for overexpressing miR-15a-5p. Western blot and quantitative real-time polymerase chain reaction analyses were conducted to quantify TIGIT and miR-15a-5p levels of pre- and post-transfection. Cell proliferation, migration, invasiveness, cell cycle distribution, and apoptosis were assessed using cell counting kit-8, wound-healing, colony formation, transwell assays, and flow cytometry, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>This study identified 139 genes (37 upregulated and 102 downregulated genes). Elevated TIGIT levels exhibited a significant link to unfavorable outcomes in individuals with breast cancer (BC). Additional analyses demonstrated that TIGIT expression in BC cell lines was substantially increased compared with that in normal breast cells. Overexpressing miR-15a-5p effectively inhibited TIGIT expression and consequently suppressed TNBC cell proliferation, invasion, and migration. This inhibition prompted G2\/M phase accumulation and enhanced cellular mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st4\">\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>miR-15a-5p exerts tumor-suppressive effects through TIGIT downregulation, thereby mitigating the malignant phenotype of TNBC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/cytojournal_40_2025","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:31:13Z","timestamp":1769859073000},"page":"6","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNA-15a-5p suppresses triple-negative breast cancer cell proliferation and invasion by modulating T-cell immunoreceptor associated with immunoglobulin and ITIM domain expression"],"prefix":"10.25259","volume":"23","author":[{"given":"Shaopeng","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Breast Oncology Surgery, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjie","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Breast Oncology Surgery, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jintao","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Breast Oncology Surgery, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Breast Oncology Surgery, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Breast Oncology Surgery, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang City, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"10.25259\/Cytojournal_40_2025\/ref-1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.25259\/Cytojournal_40_2025\/ref-2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnci\/djy106","article-title":"Triple-negative breast cancer risk genes identified by multigene hereditary cancer panel testing","volume":"110","author":"Shimelis","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.25259\/Cytojournal_40_2025\/ref-3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.24976\/Discov.Med.202436182.49","article-title":"Characterizing the efficacy and safety of chemotherapy plus everolimus in HER2-negative metastatic breast cancer harboring altered PI3K\/AKT\/mTOR","volume":"36","author":"Wang","year":"2024","journal-title":"Discov Med"},{"key":"10.25259\/Cytojournal_40_2025\/ref-4","doi-asserted-by":"publisher","first-page":"e005543","DOI":"10.1136\/jitc-2022-005543","article-title":"Anti-TGF-\u03b2\/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer","volume":"10","author":"Yi","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.25259\/Cytojournal_40_2025\/ref-5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: Small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.25259\/Cytojournal_40_2025\/ref-6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.25259\/Cytojournal_40_2025\/ref-7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.acr.2016.07.004","article-title":"MicroRNA and metastasis","volume":"132","author":"Ma","year":"2016","journal-title":"Adv Cancer Res"},{"key":"10.25259\/Cytojournal_40_2025\/ref-8","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ncb2769","article-title":"Control of metastatic progression by microRNA regulatory networks","volume":"15","author":"Pencheva","year":"2013","journal-title":"Nat Cell Biol"},{"key":"10.25259\/Cytojournal_40_2025\/ref-9","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.omtn.2022.04.011","article-title":"Microfluidics for detection of exosomes and microRNAs in cancer: State of the art","volume":"28","author":"Mousavi","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.25259\/Cytojournal_40_2025\/ref-10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/14737140.2021.1840984","article-title":"Triple-negative breast cancer: Promising prognostic biomarkers currently in development","volume":"21","author":"Sukumar","year":"2021","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.25259\/Cytojournal_40_2025\/ref-11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics-challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.25259\/Cytojournal_40_2025\/ref-12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-018-0760-x","article-title":"The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells","volume":"17","author":"Utaijaratrasmi","year":"2018","journal-title":"Mol Cancer"},{"key":"10.25259\/Cytojournal_40_2025\/ref-13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1158\/1538-7445.AM2014-1136","article-title":"p53-induced miR-15a\/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer","volume":"74","author":"Shi","year":"2014","journal-title":"Cancer Res"},{"key":"10.25259\/Cytojournal_40_2025\/ref-14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1476-4598-10-55","article-title":"miR-34a and miR-15a\/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner","volume":"10","author":"Bandi","year":"2011","journal-title":"Mol Cancer"},{"key":"10.25259\/Cytojournal_40_2025\/ref-15","doi-asserted-by":"publisher","first-page":"31944","DOI":"10.18632\/oncotarget.5128","article-title":"E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a\/16 promoter","volume":"6","author":"Chu","year":"2015","journal-title":"Oncotarget"},{"key":"10.25259\/Cytojournal_40_2025\/ref-16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.4149\/neo_2020_190808N731","article-title":"Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expression via sponging miR-15a-5p","volume":"67","author":"Yuan","year":"2020","journal-title":"Neoplasma"},{"key":"10.25259\/Cytojournal_40_2025\/ref-17","doi-asserted-by":"publisher","first-page":"8425","DOI":"10.2147\/CMAR.S333830","article-title":"Microribonucleic acid-15a-5p alters adriamycin resistance in breast cancer cells by targeting cell division cycle-associated protein 4","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.25259\/Cytojournal_40_2025\/ref-18","doi-asserted-by":"publisher","first-page":"8348450","DOI":"10.1155\/2016\/8348450","article-title":"Procaine induces epigenetic changes in HCT116 colon cancer cells","volume":"2016","author":"Sabit","year":"2016","journal-title":"Genet Res Int"},{"key":"10.25259\/Cytojournal_40_2025\/ref-19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ccell.2017.07.005","article-title":"Genomic evolution of breast cancer metastasis and relapse","volume":"32","author":"Yates","year":"2017","journal-title":"Cancer Cell"},{"key":"10.25259\/Cytojournal_40_2025\/ref-20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat Immunol"},{"key":"10.25259\/Cytojournal_40_2025\/ref-21","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1111\/jcmm.14332","article-title":"Use of aspirin in the prevention of colorectal cancer through TIGITCD155 pathway","volume":"23","author":"Ma","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.25259\/Cytojournal_40_2025\/ref-22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12964-023-01455-z","article-title":"The immune checkpoint TIGIT\/CD155 promotes the exhaustion of CD8 + T cells in TNBC through glucose metabolic reprogramming mediated by PI3K\/AKT\/mTOR signaling","volume":"22","author":"Huang","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.25259\/Cytojournal_40_2025\/ref-23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaad.2019.03.012","article-title":"Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes","volume":"81","author":"Lee","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/Cytojournal_40_2025\/ref-24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/COC.0000000000000832","article-title":"Prognostic value of the tumor immune microenvironment for early-stage, non-small cell lung cancer","volume":"44","author":"Tuminello","year":"2021","journal-title":"Am J Clin Oncol"},{"key":"10.25259\/Cytojournal_40_2025\/ref-25","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1158\/0008-5472.CAN-17-0381","article-title":"CD155T\/TIGIT signaling regulates CD8(+) T-cell metabolism and promotes tumor progression in human gastric cancer","volume":"77","author":"He","year":"2017","journal-title":"Cancer Res"},{"key":"10.25259\/Cytojournal_40_2025\/ref-26","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1158\/1078-0432.CCR-15-2626","article-title":"T-Cell immunoglobulin and ITIM domain (TIGIT) associates with CD8+ T-cell exhaustion and poor clinical outcome in AML patients","volume":"22","author":"Kong","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.25259\/Cytojournal_40_2025\/ref-27","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1182\/blood-2018-01-825265","article-title":"TIGIT immune checkpoint blockade restores CD8(+) T-cell immunity against multiple myeloma","volume":"132","author":"Guillerey","year":"2018","journal-title":"Blood"},{"key":"10.25259\/Cytojournal_40_2025\/ref-28","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","article-title":"The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function","volume":"26","author":"Johnston","year":"2014","journal-title":"Cancer Cell"},{"key":"10.25259\/Cytojournal_40_2025\/ref-29","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.25259\/Cytojournal_40_2025\/ref-30","doi-asserted-by":"publisher","first-page":"7827","DOI":"10.1038\/s41598-019-43924-x","article-title":"FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"key":"10.25259\/Cytojournal_40_2025\/ref-31","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.25259\/Cytojournal_40_2025\/ref-32","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"10.25259\/Cytojournal_40_2025\/ref-33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.omto.2022.03.010","article-title":"miR-15a and miR-15b modulate natural killer and CD8(+)T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma","volume":"25","author":"Pathania","year":"2022","journal-title":"Mol Ther Oncolytics"},{"key":"10.25259\/Cytojournal_40_2025\/ref-34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1476-4598-6-1","article-title":"OncomiRs: The discovery and progress of microRNAs in cancers","volume":"6","author":"Cho","year":"2007","journal-title":"Mol Cancer"},{"key":"10.25259\/Cytojournal_40_2025\/ref-35","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.2217\/fon.15.101","article-title":"miRNA-15a\/16: As tumor suppressors and more","volume":"11","author":"Huang","year":"2015","journal-title":"Future Oncol"},{"key":"10.25259\/Cytojournal_40_2025\/ref-36","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1002\/jcp.27342","article-title":"The miR-15a\/16 gene cluster in human cancer: A systematic review","volume":"234","author":"Liu","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.25259\/Cytojournal_40_2025\/ref-37","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3892\/ijo.2013.2034","article-title":"MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer","volume":"43","author":"Luo","year":"2013","journal-title":"Int J Oncol"},{"key":"10.25259\/Cytojournal_40_2025\/ref-38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11010-013-1762-z","article-title":"Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2\/miR-15a\/16-1 via HDAC3 in non-small cell lung cancer","volume":"383","author":"Chen","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"10.25259\/Cytojournal_40_2025\/ref-39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13048-024-01578-y","article-title":"TIGIT(+) CD4(+) regulatory T cells enhance PD-1 expression on CD8(+) T cells and promote tumor growth in a murine ovarian cancer model","volume":"17","author":"Chen","year":"2024","journal-title":"J Ovarian Res"},{"key":"10.25259\/Cytojournal_40_2025\/ref-40","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1038\/s41598-017-02800-2","article-title":"miR-15a\/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin","volume":"7","author":"Patel","year":"2017","journal-title":"Sci Rep"},{"key":"10.25259\/Cytojournal_40_2025\/ref-41","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.bbadis.2011.02.002","article-title":"MicroRNAs and the cell cycle","volume":"1812","author":"Bueno","year":"2011","journal-title":"Biochim Biophys Acta"}],"container-title":["Cytojournal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cytojournal.com\/microrna-15a-5p-suppresses-triple-negative-breast-cancer-cell-proliferation-and-invasion-by-modulating-t-cell-immunoreceptor-associated-with-immunoglobulin-and-itim-domain-expression\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cytojournal.com\/microrna-15a-5p-suppresses-triple-negative-breast-cancer-cell-proliferation-and-invasion-by-modulating-t-cell-immunoreceptor-associated-with-immunoglobulin-and-itim-domain-expression\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:31:14Z","timestamp":1769859074000},"score":1,"resource":{"primary":{"URL":"https:\/\/cytojournal.com\/microrna-15a-5p-suppresses-triple-negative-breast-cancer-cell-proliferation-and-invasion-by-modulating-t-cell-immunoreceptor-associated-with-immunoglobulin-and-itim-domain-expression\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":41,"alternative-id":["10.25259\/Cytojournal_40_2025"],"URL":"https:\/\/doi.org\/10.25259\/cytojournal_40_2025","relation":{},"ISSN":["1742-6413","0974-5963"],"issn-type":[{"value":"1742-6413","type":"electronic"},{"value":"0974-5963","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"article-number":"6"}}